Transketolase-like protein 1 confers resistance to serum withdrawal in vitro

Cancer Letters

Volumn 300, Issue 1, 2011, Pages 20-29

  Hartmannsberger, Diana ^a   Mack, Brigitte ^a   Eggert, Carola ^a   Denzel, Sabine ^b   Stepp, Herbert ^c   Betz, Christian S ^a   Gires, Olivier ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Laser Forschungslabor   (Germany)

Author keywords

Carcinoma; Pentose phosphate pathway; TKTL1

Indexed keywords

TRANSKETOLASE; TRANSKETOLASE LIKE PROTEIN 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; CELL LINE; CELL PROLIFERATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR WEIGHT; PENTOSE PHOSPHATE PATHWAY; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSKETOLASE;

EID: 78549243301     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.08.017     Document Type: Article

References (30)

1. Warburg O., Wind F., Negelein E. The Metabolism of tumors in the body. J. Gen. Physiol. 1927, 8:519-530.
2. Rais B., Comin B., Puigjaner J., Brandes J.L., Creppy E., Saboureau D., Ennamany R., Lee W.N., Boros L.G., Cascante M. Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle. FEBS Lett. 1999, 456:113-118.
3. Boros L.G., Lee P.W., Brandes J.L., Cascante M., Muscarella P., Schirmer W.J., Melvin W.S., Ellison E.C. Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism?. Med. Hypotheses 1998, 50:55-59.
4. Coy J.F., Dressler D., Wilde J., Schubert P. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin. Lab. 2005, 51:257-273.
5. Zhao J., Zhong C.J. A review on research progress of transketolase. Neurosci. Bull. 2009, 25:94-99.
6. Coy J.F., Dubel S., Kioschis P., Thomas K., Micklem G., Delius H., Poustka A. Molecular cloning of tissue-specific transcripts of a transketolase-related gene: implications for the evolution of new vertebrate genes. Genomics 1996, 32:309-316.
7. Sun W., Liu Y., Glazer C.A., Shao C., Bhan S., Demokan S., Zhao M., Rudek M.A., Ha P.K., Califano J.A. TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization. Clin. Cancer Res. 2010, 16:857-866.
8. Kohrenhagen N., Voelker H.U., Schmidt M., Kapp M., Krockenberger M., Frambach T., Dietl J., Kammerer U. Expression of transketolase-like 1 (TKTL1) and p-Akt correlates with the progression of cervical neoplasia. J. Obstet. Gynaecol. Res. 2008, 34:293-300.
9. Langbein S., Zerilli M., Zur Hausen A., Staiger W., Rensch-Boschert K., Lukan N., Popa J., Ternullo M.P., Steidler A., Weiss C., Grobholz R., Willeke F., Alken P., Stassi G., Schubert P., Coy J.F. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br. J. Cancer 2006, 94:578-585.
10. Foldi M., Stickeler E., Bau L., Kretz O., Watermann D., Gitsch G., Kayser G., Zur Hausen A., Coy J.F. Transketolase protein TKTL1 overexpression: a potential biomarker and therapeutic target in breast cancer. Oncol. Rep. 2007, 17:841-845.
11. Wu H.T., Allie N., Myer L., Govender D. Anaplastic nephroblastomas express transketolase-like enzyme 1. J. Clin. Pathol. 2009, 62:460-463.
12. Smith I.M., Glazer C.A., Mithani S.K., Ochs M.F., Sun W., Bhan S., Vostrov A., Abdullaev Z., Lobanenkov V., Gray A., Liu C., Chang S.S., Ostrow K.L., Westra W.H., Begum S., Dhara M., Califano J. Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer. PLoS ONE 2009, 4:e4961.
13. Frohlich E., Fink I., Wahl R. Is transketolase like 1 a target for the treatment of differentiated thyroid carcinoma? A study on thyroid cancer cell lines. Invest. New Drug. 2009, 27:297-303.
14. Langbein S., Frederiks W.M., zur Hausen A., Popa J., Lehmann J., Weiss C., Alken P., Coy J.F. Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer. Int. J. Cancer 2008, 122:2422-2428.
15. Chen H., Yue J.X., Yang S.H., Ding H., Zhao R.W., Zhang S. Overexpression of transketolase-like gene 1 is associated with cell proliferation in uterine cervix cancer. J. Exp. Clin. Cancer Res. 2009, 28:43.
16. Graham F.L., Smiley J., Russell W.C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 1977, 36:59-74.
17. Umland O., Ulmer A.J., Vollmer E., Goldmann T. HOPE fixation of cytospin preparations of human cells for in situ hybridization and immunocytochemistry. J. Histochem. Cytochem. 2003, 51:977-980.
18. Munz M., Kieu C., Mack B., Schmitt B., Zeidler R., Gires O. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 2004, 23:5748-5758.
19. Yuan W., Wu S., Guo J., Chen Z., Ge J., Yang P., Hu B. Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo. Cancer Biol. Ther. 2010, 9.
20. Hu L.H., Yang J.H., Zhang D.T., Zhang S., Wang L., Cai P.C., Zheng J.F., Huang J.S. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells. Anticancer Drugs 2007, 18:427-433.
21. Xu X., Zur Hausen A., Coy J.F., Lochelt M. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells. Int. J. Cancer 2009, 124:1330-1337.
22. Leong A.S. Pitfalls in diagnostic immunohistology. Adv. Anat. Pathol. 2004, 11:86-93.
23. Olert J., Wiedorn K.H., Goldmann T., Kuhl H., Mehraein Y., Scherthan H., Niketeghad F., Vollmer E., Muller A.M., Muller-Navia J. HOPE fixation: a novel fixing method and paraffin-embedding technique for human soft tissues. Pathol. Res. Pract. 2001, 197:823-826.
24. Wittig R., Coy J.F. The role of glucose metabolism and glucose-associated signalling in cancer. Perspect. Medicin. Chem. 2008, 1:64-82.
25. Schmidt M., Kammerer U., Segerer S., Cramer A., Kohrenhagen N., Dietl J., Voelker H.U. Glucose metabolism and angiogenesis in granulosa cell tumors of the ovary: activation of Akt, expression of M2PK, TKTL1 and VEGF. Eur. J. Obstet. Gynecol. Reprod. Biol. 2008, 139:72-78.
26. Zhao F., Mancuso A., Bui T.V., Tong X., Gruber J.J., Swider C.R., Sanchez P.V., Lum J.J., Sayed N., Melo J.V., Perl A.E., Carroll M., Tuttle S.W., Thompson C.B. Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprogramming. Oncogene 2010.
27. Volker H.U., Hagemann C., Coy J., Wittig R., Sommer S., Stojic J., Haubitz I., Vince G.H., Kammerer U., Monoranu C.M. Expression of transketolase-like 1 and activation of Akt in grade IV glioblastomas compared with grades II and III astrocytic gliomas. Am. J. Clin. Pathol. 2008, 130:50-57.
28. Volker H.U., Scheich M., Schmausser B., Kammerer U., Eck M. Overexpression of transketolase TKTL1 is associated with shorter survival in laryngeal squamous cell carcinomas. Eur. Arch. Otorhinolaryngol. 2007, 264:1431-1436.
29. Staiger W.I., Coy J.F., Grobholz R., Hofheinz R.D., Lukan N., Post S., Schwarzbach M.H., Willeke F. Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer. Oncol. Rep. 2006, 16:657-661.
30. Schultz H., Kahler D., Branscheid D., Vollmer E., Zabel P., Goldmann T. TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens. Diagn. Pathol. 2008, 3:35.